ERELZI

This brand name is authorized in Albania, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, South Africa, Spain, Turkey, UK.

Active ingredients

The drug ERELZI contains one active pharmaceutical ingredient (API):

1	Etanercept UNII OP401G7OJC - ETANERCEPT
	Etanercept is a competitive inhibitor of TNF binding to its cell surface receptors, and thereby inhibits the biological activity of TNF. The mechanism of action of etanercept is thought to be its competitive inhibition of TNF binding to cell surface TNFR, preventing TNF-mediated cellular responses by rendering TNF biologically inactive.
	Read more about Etanercept

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AB01	Etanercept	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AB Tumor necrosis factor alpha (TNF-α) inhibitors
Discover more medicines within L04AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	663/237, 663/237a
BR	Câmara de Regulação do Mercado de Medicamentos	511520100072407, 511520100072507
CA	Health Products and Food Branch	02462850, 02462869, 02462877
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	11089204, 11594304, 11594310, 11594327, 11594333, 11594356, 11594362, 11594379, 12671840, 13600256, 13696121, 13781223, 13781252, 13913050, 13913067, 13913073, 13913096, 14035605, 14035611, 14131906, 14131935, 14131941, 14131958, 14137369, 14137375, 14137381, 14137398, 14163786, 14163792, 14163800, 14163817, 14212266, 14212272, 14254388, 14274037, 15193542, 15200147, 15200153, 15200176, 15200182, 15746998, 15747012, 15997447, 15997453, 16036997, 16037005, 16037011, 16037028, 16702276, 16702282, 16798715, 16798721, 16798738, 16798744, 16798750, 16958024, 16958030, 17166897, 17166905, 17166934, 17166940, 17304709, 17304715, 17312465, 17396083, 17396108, 17848415, 17848421
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	231-MBE-0322, 241-MBE-1222
EE	Ravimiamet	1748460, 1748471, 1748482, 1748493, 1748505, 1748516, 1748527, 1748538, 1748549, 1748550, 1748561, 1748572, 1777495, 1777507
ES	Centro de información online de medicamentos de la AEMPS	1171195003, 1171195007, 1171195010
FI	Lääkealan turvallisuus- ja kehittämiskeskus	096150, 149166, 453029, 585085, 598281
FR	Base de données publique des médicaments	61382671, 64784134, 67270711
GB	Medicines & Healthcare Products Regulatory Agency	346338, 346340, 346342
IL	מִשְׂרַד הַבְּרִיאוּת	8654, 8655, 8656
LT	Valstybinė vaistų kontrolės tarnyba	1083188, 1083189, 1083190, 1083191, 1083192, 1083193, 1083194, 1083195, 1083196, 1083197, 1083198, 1083199, 1084550, 1084551
NL	Z-Index G-Standaard	15208826, 15208850
NL	Z-Index G-Standaard, PRK	106321, 81647, 81655
NZ	Medicines and Medical Devices Safety Authority	19579, 19594, 19595
PL	Rejestru Produktów Leczniczych	100391517, 100391523, 100391530
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W63831001, W63832001
TR	İlaç ve Tıbbi Cihaz Kurumu	8681428951178, 8681428951185, 8681428951192, 8681428951208, 8681428951215, 8681428951222, 8681428951413, 8681428951420, 8681428951437
ZA	Health Products Regulatory Authority	55/3.1/0392, 55/3.1/0393